Dehydroepiandrosterone alters the growth of stromal vascular cells from human adipose tissue

International Journal of Obesity

Volumn 23, Issue 6, 1999, Pages 595-602

  McIntosh, M K ^a   Lea Currie, Y R ^a   Geigerman, C ^a   Patseavouras, L ^b  

^a UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^b Patseavouras Ctr for Facial PLS   (United States)

Author keywords

Dehydroepiandrosterone; Human stromal vascular cells; Preadipocyte proliferation and differentiation

Indexed keywords

GLYCEROL 3 PHOSPHATE DEHYDROGENASE; LIPID; PRASTERONE; ROSIGLITAZONE; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; ARTICLE; BIOASSAY; CASE REPORT; CELL CULTURE; CELL DIFFERENTIATION; CELL METABOLISM; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; ELECTIVE SURGERY; ENZYME ANALYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPOSUCTION; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; STAINING; STROMA CELL; SUBCUTANEOUS FAT; VASCULAR TISSUE;

EID: 0033062270     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800874     Document Type: Article

References (44)

1. Orentreich N, Brind J, Rizer R, Vogelman J. Age changes and sex differences in serum DHEA-sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1985; 59: 551-555.
2. Orentreich N, Brind J, Vogelman J, Andres R, Baldwin H. Long term longitudinal measurements of plasma DHEA sulfate in normal men. J Clin Endocrinol Metab 1992; 75: 1002-1004.
3. Nestler J, Clore J, Blackard W. Dehydroepiandrosterone: The missing link between hyperinsulinemia and atherosclerosis. FASEB J 1992; 6: 3073-3075.
4. Berdanier C, Parente J, McIntosh M. Is DHEA an antiobesity agent? FASEB J 1993; 7: 414-419.
5. Coleman DL. Therapeutic effects of DHEA and its metabolites in diabetes-obesity mutants. In: Lardy H, Stratman F (eds). Hormones, Thermogenesis, and Obesity. Elsevier: New York, 1989, pp 377-384.
6. Cleary M. The antiobesity effects of DHEA in rats. Proc Soc Exp Biol Med 1991; 196: 8-16.
7. Mohan P, Ihnen J, Levin B, Cleary M. Effect of DHEA treatments with diet-induced obesity. J Nutr 1990; 120: 1103-1114.
8. Tagliaferro A, Ronan A, Payne J, Meeker L, Tse S. Increased lipolysis to beta-adrenergic stimulation after DHEA treatment in rats. Am J Physiol 1995; 268: R1374-R1380.
9. Gordon G, Newitt J, Shantz L, Weng D, Talalay P. Inhibition of the conversion of 3T3-L1 fibroblast clones to adipocytes by DHEA and related anticarcinogenic steroids. Cancer Res 1986; 46: 3389-3395.
10. Shantz L, Talalay P, Gordon G. Mechanism of inhibition of growth of 3T3-L1 fibroblasts and their differentiation to adipocytes by DHEA and related steroids: Role of G6PD. PNAS 1989; 86: 3852-3856.
11. Cleary M, Hood S, Chando C, Hansen C, Billheimer J. Response of sucrose-fed rats to DHEA. Nutr Res 1984; 4: 485-494.
12. Nestler J, Barlascini C, Clore J, Blackard W. DHEA reduces serum LDL levels and body fat but does not alter insulin sensitivity in older men. J Clin Endocrinol Metab 1988; 66: 57-61.
13. Jakubowicz J, Beer N, Rengifo R. Effect of DHEA on c-GMP and body composition in men of advancing age. Ann NY Acad Sci 1995; 774: 312-315.
14. Morales A, Nolan J, Nelson J, Yen S. Effects of replacement dose of DHEA in men and women of advancing age. J Clin Endocrinol Metab 1994; 78: 1360-1367.
15. Yen S, Morales A, Khorram O. Replacement of DHEA in aging men and women. Potential remedial effects. Ann NY Acad Sci 1995; 774: 128-142.
16. Lea-Curric R, Wu S, McIntosh M. Effects of acute administration of dehydroepiandrosterone sulfate on adipose tissue mass and cellularity in male rats. Int J Obes 1997; 21: 147-154.
17. Lea-Currie YR, Wen P, McIntosh M. Dehydroepiandrosterone sulfate attenuates adipocyte hyperplasia associated with feeding rats a high fat diet. Int J Obes 1997; 21: 1058-1064.
18. Wen P, Lea-Currie R, Alexander E, McIntosh M. Dehydroepiandrosterone reduces proliferation and differentiation of 3T3-L1 preadipocytes. Biochem Biophys Res Commun 1998; 248: 497-504.
19. McIntosh M, Hausman D, Martin R, Hausman G. Dehydroepiandrosterone (DHEA) attenuates preadipocyte proliferation and differentiation in primary cultures of stromal-vascular cells. Am J Physiol (Endocrinol Metab) 1998; 275: E285-E293.
20. Entermann G, Hauner H. Relationship between replication and differentiation in cultured human adipocyte precurser cells. Am J Physiol (Cell Physiol) 1996; 270: C1011- 1016.
21. Goegan P, Johnson G, Vincent R. Effects of serum protein and colloid on the AlamarBlue Assay in cell cultures. Toxic In Vitro 1995; 9: 257-266.
22. Phillips M, Enam E, Liu P, Matsumura F. Inhibition of 3T3-L1 adipose differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Cell Sci 1995; 108: 395-402.
23. Steele R, Torrie J. Principles and Procedures of Statistics. McGraw-Hill: New York, 1980.
24. Haffner S, Valdez R. Decreased testosterone and DHEAS concentrations are associated with increased insulin and glucose concentrations in nondiabetic men. Metabolism 1994; 43: 599-603.
25. Lopez S, Krehl W. A possible relationship between glucose-6-phosphate dehydrogenase and DHEA in obesity. Lancet 1967; 2: 485-487.
26. DePergola G, Giagulli V, Garruti G, Cospite M, Giorgino F, Cignarelli M, Giorgino R. Low DHEA levels in premenopausal obese women with very high body mass index. Metabolism 1991; 40: 187-190.
27. DePergola G, Triggiani V, Giorgino F, Cospite M, Garruti G, Cignarelli, M, Guastamacchia E, Giorgino R. The free testosterone to DHEAS molar ratio as a marker of visceral fat accumulation in premenopausal obese women. Int J Obes 1994; 18: 659-664.
28. Williams D, Boyden T, Pamenter R, Lohman T, Going S. Relationship of body fat percentage and fat distribution with dehydroepiandrosterone sulfate in premenopausal women. J Clin Endocrinol Metab 1993; 77: 80-85.
29. Martin R, Hausman G, Hausman D. Regulation of adipose cell development in utero. Proc Soc Exp Biol Med 1998; 219: 200-210
30. Schultz S, Klann R, Schonfeld S, Nyce J. Mechanism of cell growth and inhibition and cell cycle arrest in human colonic adenocarcinoma cells by dehydroepiandrosterone: Role of isoprenoid biosynthesis. Cancer Res 1992; 52: 1372-1376.
31. Maltese W. Covalent modification of proteins by farnesol and the control of cell proliferation. In: Columanp A, Feo F, Pascale R, Pani P (eds). Chemical Carcinogenesis: Modulating Factors Vol. II. Plenum Press: New York, 1991, pp 327-335.
32. Pascale R, Simile M, De Miglio M, Nufris A, Seddaiu M. Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase activity and gene expression by dehydroepiandrosterone in prenoplastic liver nodules. Carcinogenesis 1995; 16: 1537-1542.
33. Nishio E, Tomiyama K, Nakata H, Watanabe Y. 3-hydroxy-3-methylglutaryl A reductase inhibitor impairs cell differentiation in cultures adipogenic cells (3T3-L1). Eur J Pharmacol 1996; 301: 203-206.
34. Chawla A, Lazar M. Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival. Proc Natl Acad Sci USA 1994; 92: 1786-1790.
35. Lehmann J, Moore L, Smith-Oliver T, Wilkison W, Wilson T. An antidiabetic thiazolidinedione is a high affinity ligarid for peroxisome proliferator-activated receptor g (PPAR-γ). J Biol Chem 1995; 270: 12953-12956.
36. Tontonoz P, Hu E, Spiegelman B. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 1994; 79: 1147-1156.
37. Tontonoz P, Hu E, Graves R, Budavari A, Spiegelman B. mPPARγ2: Tissue-specific regulator of an adipocyte enhancer. Genes Dev 1994; 8: 1224-1234.
38. Rao M, Subbarau V, Yeldandi A, Reddy J. Hepatoearcinogenicity of dehydroepiandrosterone in the rat. Cancer Res 1992; 52: 2977-2979.
39. Prasanna H, Hart R, Magee P. Recent studies on the effects of DHEA on the metabolism of carcinogens in vivo. J Toxicol Toxin Rev 1989; 8: 121-131.
40. Yamada J, Sakuma, M, Suga T. Induction of peroxisomal β-oxidation enzymes by dehydroepiandrosterone and its sulfate in primary cultures of rat hepatocytes. Biochim Biophys Acta 1992; 1137: 231-236.
41. Catt K. Molecular mechanisms of hormone action: Control of target cell function by peptide, steroid and thyroid hormones. In: Felig P, Baxter J, Broadus A, Frohman L (eds). Endocrinology and Metabolism (2nd Edn). McGraw-Hill: New York, 1987, 82-160.
42. Santos R, Sztalryd C, Reavan G. Effect of anatomical site on insulin action and insulin receptor phosphorylation in isolated rat adipocytes. Int J Obes 1991; 15: 755-762.
43. Bolinder J, Kager L, Ostman J, Ameer P. Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 1983; 32: 117-123.
44. Bouchard C, Després J-P, Maureige P. Genetic and nongenetic determinants of regional fat distribution. Endocr Rev 1993; 14: 72-93.